Form 4: Progyny Director Trades Common Stock

Progyny Director Cheryl Scott reports transactions involving common stock and stock options, including acquisitions and dispositions.

Summary

• Director Cheryl Scott of Progyny, Inc. (PGNY) reported several transactions on June 1, 2026.
• These transactions include the acquisition of 14,667 shares of common stock at a price of $13 per share.
• Additionally, 7,228 shares were disposed of at $26.38 per share, and another 7,439 shares were disposed of at $26.385 per share.
• Following these transactions, Scott beneficially owns 19,772 shares of common stock directly.
• The filing also details a stock option grant for 14,667 shares, with an exercise price of $13, exercisable until October 23, 2029. A portion of these options vests monthly starting October 24, 2020, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It represents routine insider transactions and stock option activity, with no strong indicators of significant positive or negative sentiment regarding the company's performance or future prospects.

Positives

• Acquisition of 14,667 shares of common stock at a favorable price of $13 per share.
• Stock option grant with a potential for future gains, with vesting scheduled to begin in October 2020.

Negatives

• Disposition of a significant number of shares (7,228 and 7,439) at prices slightly above the acquisition price, potentially indicating profit-taking or a need for liquidity.
• The exercise price of the stock option ($13) is lower than the disposition prices ($26.38 and $26.385), suggesting the option was granted at a lower valuation point.

Risks

• The vesting schedule for stock options is contingent on continued service, meaning any departure from the company could forfeit unvested options.
• The disposition of shares could be interpreted as a lack of confidence in future price appreciation, although this is a standard Form 4 filing and may represent pre-planned sales or diversification.

Future Outlook

The filing indicates a stock option grant with a vesting schedule extending over several years, suggesting a long-term incentive for the director. The specific terms of the option suggest a potential for future value realization if the company's stock price increases.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The reported trades by Director Cheryl Scott at Progyny, Inc. are typical for executives managing their equity holdings, including exercising options and selling shares, often as part of pre-arranged trading plans.

Stakeholder Impact

• Shareholders: The disposition of shares by a director may be observed, but without further context, it's difficult to ascertain the impact. It could represent personal financial planning or a signal about future stock performance.
• Employees: The stock option grant indicates continued incentive for management and key personnel.
• Management: The transactions reflect standard equity management practices for company leadership.

Next Steps

• Continued vesting of stock options according to the schedule, contingent on service.
• Potential future transactions by the reporting person as disclosed in subsequent filings.

Key Dates

Keywords

Progyny, PGNY, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Cheryl Scott, Director, Securities Transaction